Longitudinal changes in electrophysiological findings caused by nusinersen administration in patients with spinal muscular atrophy type 2 or type 3

被引：0
|
作者：
Arahata, Y. [1 ]
Ishiyama, A. [1 ]
Takeshita, E. [1 ]
Shimizu-Motohashi, Y. [1 ]
Komaki, H. [1 ]
Sasaki, M. [1 ]
机构：
[1] Natl Ctr Hosp, NCNP, Tokyo, Japan
来源：
NEUROMUSCULAR DISORDERS | 2019年 / 29卷
关键词：
D O I：
10.1016/j.nmd.2019.06.535
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.373
引用
收藏
页码：S190 / S190
页数：1
相关论文
共 50 条
  • [41] Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 Patients
    Bianchi, Laura
    Sframeli, Maria
    Vantaggiato, Lorenza
    Vita, Gian Luca
    Ciranni, Annamaria
    Polito, Francesca
    Oteri, Rosaria
    Gitto, Eloisa
    Di Giuseppe, Fabrizio
    Angelucci, Stefania
    Versaci, Antonio
    Messina, Sonia
    Vita, Giuseppe
    Bini, Luca
    Aguennouz, M'hammed
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [42] First experience of Nusinersen early access program in patients with spinal muscular atrophy type 1
    Gargaun, E.
    Aragon-Gawinska, K.
    Seferian, A.
    Gidaro, T.
    Gilabert, S.
    Lilien, C.
    Colcer, A.
    Boukouti, K.
    Vuillerot, C.
    Cances, C.
    Daron, A.
    Annousamy, M.
    De, A.
    Berliac, L. Flet
    Armier, H.
    Fiedler, L.
    Servais, L.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S211 - S212
  • [43] Combination of nusinersen and rehabilitation using hybrid assistive limb for type 3 spinal muscular atrophy
    Tsuda, Yo
    Ueki, Yoshino
    Kawaguchi, Takatsune
    Taniguchi, Yoko
    Madokoro, Yuta
    Kobayashi, Takafumi
    Hattori, Ayako
    Kashima, Shuto
    Hibino, Hiroaki
    Saitoh, Shinji
    Matsukawa, Noriyuki
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2025, 13 (01): : 83 - 85
  • [44] Characterization of patients with Type 1 Spinal Muscular Atrophy in advanced disease state treated with Nusinersen
    Balkenhol, J.
    Beytia, M.
    Jofre, J.
    Suarez, B.
    Hervias, C.
    Calcagno, G.
    Castiglioni, C.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [45] Evolution of bulbar function in spinal muscular atrophy type 1 treated with nusinersen
    Weststrate, Harriet
    Stimpson, Georgia
    Thomas, Lily
    Scoto, Mariacristina
    Johnson, Emily
    Stewart, Alexandra
    Muntoni, Francesco
    Baranello, Giovanni
    Conway, Eleanor
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2022, 64 (07): : 907 - 914
  • [46] The Impact of Nusinersen and Risdiplam on Motor Function for Spinal Muscular Atrophy Type 2 and 3: A Meta-Analysis
    Chen, Bo
    Gong, Yuanlin
    Zhou, Tengteng
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (08): : 948 - 955
  • [47] Effectiveness of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Croatian Real-World Data
    Belancic, Andrej
    Strbad, Tea
    Stiglic, Marta Kucan
    Vitezic, Dinko
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
  • [48] Outcomes in type 1 spinal muscular atrophy on nusinersen: A single center experience
    Zhang, Chao
    Figueroa, Janet
    Ritchey, Mary
    Razdan, Raj
    Verma, Sumit
    CLINICAL NEUROPHYSIOLOGY, 2020, 131 (12) : 2793 - 2794
  • [49] Respiratory characteristics in children with spinal muscular atrophy type 1 receiving nusinersen
    Xiao, Lena
    Chiang, Jackie
    Castro-Codesal, Maria
    Kolski, Hanna
    Bedi, Prabhjot
    Al Amrani, Fatema
    Gonorazky, Hernan D.
    Amin, Reshma
    PEDIATRIC PULMONOLOGY, 2023, 58 (01) : 161 - 170
  • [50] Sleep architecture and Nusinersen therapy in children with Spinal Muscular Atrophy type 1
    Verrillo, Elisabetta
    Pavone, Martino
    Bruni, Oliviero
    Ferri, Raffaele
    Testa, Maria Beatrice Chiarini
    Cherchi, Claudio
    D'Amico, Adele
    Cutrera, Renato
    SLEEP MEDICINE, 2023, 110 : 106 - 110
12345